The company – led by Mark McKenna, formerly chief executive of Prometheus Bio, which was sold to MSD for $10.8 billion ... Rock Springs Capital, Logos Capital, Woodline, and Acuta Capital ...

CDMOs Expand Capabilities Amid Surge in Clinical Trials and Demand for Orphan Drugs and Novel TherapiesDublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator API CDMO Market Size, ...

The pharmaceutical industry has a crucial role in modern healthcare, but it also has a significant environmental footprint. From large-scale solvent use and carbon emissions to water pollution and ...

Sol-Gel Technologies (SLGL) entered into a product purchase agreement with a subsidiary of Mayne Pharma Group (MAYNF) for the sale and exclusive license of the U.S. rights to EPSOLAY and TWYNEO.

The global Latin America Advanced Wound Care Market, valued at US$285.9 million in 2024, is forecasted to grow at a robust CAGR of 9.8%, reaching US$312.8 million in 2025 and an impressive US$498.2 ...

There has been a lot of talk about drugs targeting both PD-1 and VEGF stealing the crown held by MSD's Keytruda in cancer immunotherapy. Now, the company has made a move to try to make sure it isn ...

Zealand Pharma (ZLDPF) announces the implementation of long-term incentive programs for 2025 for Zealand Pharma’s Board of Directors, Corporate Management and employees in accordance with ...

MADRID, April 22, 2025 /PRNewswire/ -- Suanfarma, a global company specializing in the development, production, and commercialization of active pharmaceutical ingredients (APIs) and high-value ...

LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...

IPC Indice de Precios Y Cotizaciones 53,522.11 503.54 0.95% ...